Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, delivers a speech at AstraZeneca R&D China Science Day held in Shanghai from Friday to Saturday. [Photo provided to chinadaily.
-
-
Recent Updates
- China’s Methanol Revolution: A Success Story in Clean Transport Innovation
- MariBank Expanding as Southeast Asian Tech Firm Builds Regional Digital Banking Group in Singapore
- How China’s CXMT listing in Shanghai put a huge dent in the KOSPI
- China’s Memory Giant CXMT Announces Plans for Second Chip Plant in Beijing
- Alibaba Launches Revolutionary AI Model Outrivaling ChatGPT and Fable in China’s AI Competition
- US Rare Earth Independence Amid China Dominance Concerns
- U.S. Struggles to Break China’s Rare Earth Monopoly
- China’s CXMT Close to Mass Producing LPDDR6 Memory: Enhanced Performance for Next-Gen Phones
- CXMT Plans Second Beijing Plant Amid Global Chip Shortage
- CXMT Plans Second Chip Plant in Beijing Amid Rapid Expansion
Blogroll